Additional Information
Book Details
Abstract
Prevent, evaluate, and manage diseases that can be acquired in tropical environments and foreign countries with The Travel and Tropical Medicine Manual. This pragmatic, pocket-sized resource equips medical providers with the knowledge they need to offer effective aid, covering key topics in pre- and post-travel medicine, caring for immigrants and refugees, and working in low-resource settings. It's also the perfect source for travelers seeking quick, easy access to the latest travel medicine information.
- Dynamic images illustrate key concepts for an enhanced visual understanding.
- Evidence-based treatment recommendations enable you to manage diseases confidently.
- Pocket-sized format provides access to need-to-know information quickly and easily.
- Highlights new evidence and content surrounding mental health and traveling.
- Covers emerging hot topics such as Ebola virus disease, viral hemorrhagic fevers, the role of point-of-care testing in travel medicine, and antibiotic-resistant bacteria in returning travelers and students traveling abroad.
- Includes an enhanced drug appendix in the back of the book.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| The Travel and Tropical Medicine Manual | iii | ||
| Copyright Page | iv | ||
| Contents | v | ||
| Dedication | ii | ||
| Preface | ix | ||
| Contributors | x | ||
| SECTION 1: PRE-TRAVELADVICE | 1 | ||
| CHAPTER 1. Approach to Travel Medicine and a Personal Travel Medicine Kit | 1 | ||
| APPROACH TO TRAVEL MEDICINE | 2 | ||
| MEDICAL EMERGENCIES DURING TRAVEL | 8 | ||
| WILDERNESS AND ADVENTURE TRAVEL | 12 | ||
| THE TRAVELER'S MEDICAL KIT | 12 | ||
| SUMMARY OF CONSIDERATIONS FOR HEALTH AND TRAVEL | 12 | ||
| FURTHER READING | 17 | ||
| CHAPTER 2. Urban Medicine: Threats to Health of Travelers to Developing World Cities | 18 | ||
| INFECTIOUS DISEASES | 19 | ||
| TRAUMA | 20 | ||
| AIR POLLUTION | 22 | ||
| HEAT ILLNESS | 24 | ||
| CRIME AND SECURITY | 26 | ||
| PSYCHIATRIC ILLNESS | 28 | ||
| ILLICIT DRUG USE | 29 | ||
| CONCLUSIONS | 30 | ||
| FURTHER READING | 30 | ||
| CHAPTER 3. Emerging Diseases and the International Traveler | 33 | ||
| APPROACH TO INTERNATIONAL TRAVELERS | 34 | ||
| EMERGING AND RE-EMERGING ZOONOSES | 35 | ||
| VECTORED DISEASES | 35 | ||
| RESPIRATORY DISEASES | 38 | ||
| FOOD- AND WATER-BORNE DISEASES | 38 | ||
| INFORMATION RESOURCES FOR EMERGING INFECTIOUS DISEASES | 39 | ||
| FURTHER READING | 39 | ||
| CHAPTER 4. Air Carrier Issues in Travel Medicine | 41 | ||
| CABIN AIR QUALITY | 41 | ||
| RESPIRATORY DISEASE TRANSMISSION ISSUES | 45 | ||
| DENIAL OF BOARDING/PASSENGER ACCEPTANCE | 46 | ||
| IN-FLIGHT MEDICAL EMERGENCIES | 47 | ||
| FURTHER READING | 49 | ||
| CHAPTER 5. Immunizations for Travelers | 50 | ||
| ROUTINE IMMUNIZATIONS | 50 | ||
| REQUIRED TRAVEL IMMUNIZATIONS | 54 | ||
| RECOMMENDED TRAVEL VACCINES | 61 | ||
| CONCLUSION | 74 | ||
| FURTHER READING | 74 | ||
| CHAPTER 6. Malaria Prevention | 76 | ||
| APPROACH TO MALARIA PREVENTION | 76 | ||
| CURRENT CHEMOPROPHYLACTIC DRUG REGIMENS | 80 | ||
| OTHER DRUGS | 91 | ||
| STANDBY EMERGENCY MALARIA THERAPY (SBET) | 93 | ||
| SBET to Avoid | 94 | ||
| SPECIAL THERAPEUTIC CONSIDERATIONS | 95 | ||
| PRIMAQUINE FOR RELAPSE PREVENTION | 97 | ||
| FURTHER READING | 98 | ||
| CHAPTER 7. Traveler's Diarrhea: Prevention and Self-Treatment | 100 | ||
| ETIOLOGY | 102 | ||
| PREVENTION OF TRAVELER’S DIARRHEA | 103 | ||
| EMPIRIC SELF-TREATMENT | 105 | ||
| SPECIAL CONSIDERATIONS | 109 | ||
| CHOLERA EPIDEMICS IN THE WESTERN HEMISPHERE, ASIA AND AFRICA | 109 | ||
| FURTHER READING | 111 | ||
| CHAPTER 8. Water Disinfection | 112 | ||
| RISK OF WATER-BORNE INFECTION | 112 | ||
| FIELD TECHNIQUES FOR WATER TREATMENT | 114 | ||
| CLARIFICATION | 117 | ||
| CHEMICALS | 121 | ||
| FURTHER READING | 131 | ||
| CHAPTER 9. Motion, Cold and Heat Disorders | 132 | ||
| JET-LAG | 132 | ||
| MOTION SICKNESS | 137 | ||
| COLD EXPOSURE | 140 | ||
| HEAT ILLNESS | 143 | ||
| FURTHER READING | 149 | ||
| SECTION 2: ADVICE FOR SPECIAL TRAVELERS | 152 | ||
| CHAPTER 10. Altitude Illness | 152 | ||
| NORMAL ACCLIMaTIZATION | 152 | ||
| INCIDENCE | 152 | ||
| RISK FACTORS | 153 | ||
| PREVENTION OF ALTITUDE ILLNESS | 153 | ||
| ACUTE MOUNTAIN SICKNESS AND HIGH ALTITUDE CEREBRAL EDEMA | 154 | ||
| HIGH ALTITUDE PULMONARY EDEMA | 156 | ||
| RE-ASCENT AFTER ALTITUDE ILLNESS | 158 | ||
| PRE-EXISTING CONDITIONS AT ALTITUDE AND SPECIAL POPULATIONS | 158 | ||
| DIVING AT ALTITUDE | 162 | ||
| FURTHER READING | 162 | ||
| CHAPTER 11. Diving Medicine | 164 | ||
| TYPES OF RECREATIONAL DIVING | 164 | ||
| DIVING PHYSIOLOGY | 165 | ||
| BAROTRAUMA | 167 | ||
| PULMONARY OVERPRESSURIZATION SYNDROME | 169 | ||
| DECOMPRESSION SICKNESS | 171 | ||
| NITROGEN NARCOSIS | 174 | ||
| SPECIAL SITUATIONS | 174 | ||
| EVALUATION/TREATMENT | 179 | ||
| RETURNING TO DIVING | 184 | ||
| DCS | 184 | ||
| MEDICAL EVALUATIONS FOR DIVING | 184 | ||
| CONCLUSIONS | 186 | ||
| FURTHER READING | 186 | ||
| CHAPTER 12. Travel Advice for Pediatric Travelers: Infants, Children, and Adolescents | 188 | ||
| DEVELOPMENTAL ASPECTS AND TRAVEL | 188 | ||
| AIRLINE TRAVEL | 189 | ||
| MOTION SICKNESS | 190 | ||
| VACCINE SCHEDULES FOR INFANTS AND CHILDREN | 191 | ||
| MALARIA PREVENTION | 196 | ||
| DIARRHEA PREVENTION AND TREATMENT | 199 | ||
| GENERAL SAFETY FOR TRAVELING CHILDREN AND ADOLESCENTS | 202 | ||
| ALTITUDE | 202 | ||
| MISCELLANEOUS ISSUES FOR YOUNG TRAVELERS | 203 | ||
| FURTHER READING | 204 | ||
| CHAPTER 13. Advice for Women Travelers | 206 | ||
| GENDER-BASED MEDICINE | 206 | ||
| GENDER-RELATED ISSUES IN TROPICAL DISEASE | 207 | ||
| GENERAL HEALTH ISSUES OF WOMEN TRAVELERS | 208 | ||
| TRAVEL DURING PREGNANCY | 223 | ||
| FDA Use-in-pregnancy Ratings | 227 | ||
| TRAVEL ISSUES DURING BREAST-FEEDING | 238 | ||
| OLDER WOMEN TRAVELERS | 238 | ||
| PERSONAL SECURITY AND SAFETY ISSUES | 239 | ||
| SUMMARY | 239 | ||
| FURTHER READING | 239 | ||
| CHAPTER 14. Travel and HIV Infection | 241 | ||
| THE HIV-INFECTED TRAVELER | 241 | ||
| HIV-UNINFECTED TRAVELER | 252 | ||
| FURTHER READING | 253 | ||
| CHAPTER 15. Travel with Chronic Medical Conditions | 255 | ||
| CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ASTHMA AND OTHER RESPIRATORY CONDITIONS | 256 | ||
| CARDIOVASCULAR DISEASE | 260 | ||
| DIABETES MELLITUS | 262 | ||
| ARTIFICIAL HIP JOINTS AND OTHER ORTHOPEDIC HARDWARE | 268 | ||
| TRAVELING WITH CHRONIC PSYCHIATRIC CONDITIONS | 268 | ||
| FURTHER READING | 269 | ||
| CHAPTER 16. Pre-Travel Risk Assessment and Health Advice for Missionaries and Other Long-Term Expatriate Volunteers | 271 | ||
| PRE-TRAVEL HEALTH ASSESSMENT | 271 | ||
| ANALYSIS OF FITNESS FOR TRAVEL | 273 | ||
| PRE-TRAVEL IMMUNIZATIONS | 273 | ||
| PROPHYLACTIC MEDICATIONS | 275 | ||
| SAFE LIVING ABROAD | 276 | ||
| MEDICAL PROBLEMS ABROAD | 277 | ||
| SEEKING MEDICAL CARE ABROAD | 277 | ||
| POST-TRAVEL HEALTH SCREENING | 278 | ||
| FURTHER READING | 279 | ||
| CHAPTER 17. The Business Expatriate | 281 | ||
| Further Reading | 289 | ||
| CHAPTER 18. Health Screening in Immigrants, Refugees, and International Adoptees | 292 | ||
| MANDATORY IMMIGRATION SCREENING IN THE USA – MEDICAL COMPONENT | 293 | ||
| MEDICAL SCREENING OF NEW ARRIVALS IN THE USA | 297 | ||
| FURTHER READING | 302 | ||
| SECTION 3: FEVER | 303 | ||
| CHAPTER 19. Malaria Diagnosis and Treatment | 303 | ||
| GENERAL CONSIDERATIONS | 303 | ||
| ETIOLOGY | 303 | ||
| PRESENTATION | 304 | ||
| PATHOGENESIS | 305 | ||
| CLINICAL FEATURES | 306 | ||
| LABORATORY DIAGNOSIS | 308 | ||
| TREATMENT | 311 | ||
| SPECIAL THERAPEUTIC CONSIDERATIONS | 316 | ||
| COMMONLY ENCOUNTERED PRACTICAL PROBLEMS | 318 | ||
| FURTHER READING | 320 | ||
| CHAPTER 20. Travel-acquired Illnesses Associated with Fever | 322 | ||
| EPIDEMIOLOGY | 322 | ||
| MEDICAL HISTORY | 325 | ||
| INFECTIOUS DISEASES IN THE TRAVELER WITH FEVER | 333 | ||
| APPROACH TO THE TRAVELER WITH FEVER | 348 | ||
| FURTHER READING | 349 | ||
| CHAPTER 21. Viral Hepatitis in Travelers and Immigrants | 351 | ||
| EPIDEMIOLOGY AND ETIOLOGY | 353 | ||
| CLINICAL SYNDROMES | 357 | ||
| DIFFERENTIAL DIAGNOSIS | 359 | ||
| DIAGNOSIS | 361 | ||
| TREATMENT | 366 | ||
| PREVENTION | 367 | ||
| FURTHER READING | 369 | ||
| CHAPTER 22. Leptospirosis | 370 | ||
| ETIOLOGY | 370 | ||
| EPIDEMIOLOGY | 370 | ||
| CLINICAL | 373 | ||
| DIFFERENTIAL DIAGNOSIS | 375 | ||
| DIAGNOSIS | 375 | ||
| LABORATORY AND RADIOLOGIC FINDINGS | 376 | ||
| TREATMENT | 377 | ||
| PREVENTION | 377 | ||
| FURTHER READING | 378 | ||
| CHAPTER 23. Lyme Disease | 380 | ||
| CAUSATIVE ORGANISM | 380 | ||
| TRANSMISSION | 381 | ||
| EPIDEMIOLOGY | 382 | ||
| CLINICAL MANIFESTATIONS | 382 | ||
| DIAGNOSIS | 384 | ||
| THERAPY | 386 | ||
| PREVENTION | 388 | ||
| FURTHER READING | 389 | ||
| CHAPTER 24. Tuberculosis in Travelers and Immigrants | 391 | ||
| EPIDEMIOLOGY | 392 | ||
| ETIOLOGY | 394 | ||
| PATHOGENESIS | 394 | ||
| CLINICAL FEATURES | 395 | ||
| DIAGNOSIS | 396 | ||
| TREATMENT | 400 | ||
| PREVENTION | 404 | ||
| FURTHER READING | 405 | ||
| CHAPTER 25. Chagas' Disease | 407 | ||
| EPIDEMIOLOGY | 407 | ||
| TRANSFUSION- AND ORGAN TRANSPLANT-RELATED TRANSMISSION | 410 | ||
| CONGENITAL TRANSMISSION | 411 | ||
| CLINICAL FEATURES | 411 | ||
| DIAGNOSIS | 412 | ||
| EVALUATION AND TREATMENT | 415 | ||
| PROGNOSIS | 416 | ||
| PREVENTION | 417 | ||
| FURTHER READING | 417 | ||
| CHAPTER 26. African Trypanosomiasis (African Sleeping Sickness) | 419 | ||
| EPIDEMIOLOGY | 419 | ||
| LIFE CYCLE AND TRANSMISSION | 421 | ||
| PATHOGENESIS | 422 | ||
| CLINICAL FEATURES | 422 | ||
| DIAGNOSIS | 424 | ||
| DIFFERENTIAL DIAGNOSIS | 425 | ||
| TREATMENT | 425 | ||
| PREVENTION | 427 | ||
| FURTHER READING | 428 | ||
| SECTION 4: DIARRHEA | 430 | ||
| CHAPTER 27. Approach to Diarrhea in Returned Travelers | 430 | ||
| HISTORY AND EPIDEMIOLOGY | 430 | ||
| CLINICAL FEATURES | 431 | ||
| LABORATORY STUDIES | 433 | ||
| DIARRHEA SYNDROMES | 439 | ||
| SALMONELLA | 439 | ||
| SHIGELLA | 441 | ||
| CAMPYLOBACTER | 442 | ||
| YERSINIA ENTEROCOLITICA | 442 | ||
| VIBRIO | 443 | ||
| CLOSTRIDIUM DIFFICILE | 444 | ||
| NOROVIRUS | 445 | ||
| CHRONIC DIARRHEA | 445 | ||
| UNDIAGNOSED INFECTION | 445 | ||
| MALABSORPTION | 445 | ||
| PREVIOUSLY UNDIAGNOSED GASTROINTESTINAL DISEASE | 446 | ||
| DIAGNOSTIC APPROACH | 446 | ||
| THERAPEUTIC APPROACH | 446 | ||
| CHAPTER 28. Amebiasis, Giardiasis, and Other Intestinal Protozoan Infections | 448 | ||
| ENTAMOEBA HISTOLYTICA | 448 | ||
| GIARDIA LAMBLIA | 456 | ||
| OTHER PROTOZOA | 462 | ||
| OTHER PROTOZOAN PATHOGENS | 464 | ||
| POSSIBLE PATHOGEN | 465 | ||
| NON-PATHOGENIC PROTOZOA | 465 | ||
| FURTHER READING | 465 | ||
| CHAPTER 29. Food Poisoning: Toxic Syndromes | 467 | ||
| FOOD POISONING PRESENTING AS GASTROINTESTINAL ILLNESS | 467 | ||
| PIGBEL | 470 | ||
| BOTULISM | 470 | ||
| INFANT BOTULISM | 472 | ||
| ADVICE TO TRAVELERS | 472 | ||
| FURTHER READING | 472 | ||
| CHAPTER 30. Fish and Shellfish Poisoning: Toxic Syndromes | 474 | ||
| SCOMBROID FISH POISONING | 474 | ||
| CIGUATERA FISH POISONING | 475 | ||
| PUFFER FISH POISONING (TETRODOTOXIN POISONING) | 476 | ||
| BOTULISM TOXIN E | 477 | ||
| PARALYTIC SHELLFISH POISONING | 478 | ||
| NEUROTOXIC SHELLFISH POISONING (NON-PARALYTIC) | 478 | ||
| DIARRHETIC SHELLFISH POISONING | 479 | ||
| AMNESIC SHELLFISH POISONING | 479 | ||
| FURTHER READING | 479 | ||
| SECTION 5: SKIN LESIONS | 481 | ||
| CHAPTER 31. Approach to Tropical Dermatology | 481 | ||
| CLINICAL APPROACH | 481 | ||
| GENERAL DERMATOLOGIC TREATMENTS | 482 | ||
| FURTHER READING | 485 | ||
| CHAPTER 32. Acute Skin Reactions and Bacterial Infections | 486 | ||
| SUNBURN AND OTHER ULTRAVIOLET LIGHT REACTIONS | 486 | ||
| DERMATITIS IN TRAVELERS | 488 | ||
| DRUG ERUPTIONS | 490 | ||
| ARTHROPOD BITES AND STINGS | 492 | ||
| PYODERMA | 495 | ||
| PYOMYOSITIS | 497 | ||
| BURULI ULCER | 498 | ||
| TROPICAL ULCER | 499 | ||
| CUTANEOUS DIPHTHERIA | 500 | ||
| CUTANEOUS TULAREMIA | 501 | ||
| CUTANEOUS ANTHRAX | 502 | ||
| CUTANEOUS MELIOIDOSIS | 502 | ||
| FURTHER READING | 503 | ||
| CHAPTER 33. Ectoparasites, Cutaneous Parasites, and Cnidarian Envenomation | 505 | ||
| ECTOPARASITES | 505 | ||
| CUTANEOUS LARVA MIGRANS | 508 | ||
| MYIASIS | 509 | ||
| TUNGIASIS | 510 | ||
| TICK BITES | 511 | ||
| CERCARIAL DERMATITIS | 513 | ||
| CNIDARIAN (COELENTERATE) ENVENOMATION | 513 | ||
| FURTHER READING | 515 | ||
| CHAPTER 34. Fungal Skin Infections | 517 | ||
| SUPERFICIAL CUTANEOUS MYCOSES | 517 | ||
| SUBCUTANEOUS MYCOSES | 526 | ||
| FURTHER READING | 530 | ||
| CHAPTER 35. Leishmaniasis | 532 | ||
| CLINICAL MANIFESTATIONS | 532 | ||
| CUTANEOUS LEISHMANIASIS | 533 | ||
| VISCERAL LEISHMANIASIS | 539 | ||
| FURTHER READING | 541 | ||
| CHAPTER 36. Leprosy (Hansen's Disease) | 543 | ||
| ETIOLOGY | 543 | ||
| EPIDEMIOLOGY | 544 | ||
| CLINICAL FEATURES | 545 | ||
| REACTIONAL STATES | 548 | ||
| DIAGNOSIS | 549 | ||
| DIAGNOSTIC STUDIES | 549 | ||
| TREATMENT | 551 | ||
| FURTHER READING | 554 | ||
| SECTION 6: SEXUALLY TRANSMITTED DISEASES | 555 | ||
| CHAPTER 37. Sexually Transmitted Infections and Foreign Travel | 555 | ||
| CASUAL SEXUKAL ACTIVITY AND TRAVAL | 555 | ||
| SEXUAL TOURISM | 556 | ||
| THE INTERNATIONAL SPREAD OF HIV | 557 | ||
| RISKS FOR ACQUISITION OF STD AND HIV DURING TRAVEL | 557 | ||
| CONDOMS | 558 | ||
| ADVICE TO TRAVELERS | 559 | ||
| FURTHER READING | 560 | ||
| CHAPTER 38. Gonococcal and Chlamydial Genital Infections, and Pelvic Inflammatory Disease | 562 | ||
| EPIDEMIOLOGY | 562 | ||
| URETHRITIS | 563 | ||
| CERVICITIS | 564 | ||
| PELVIC INFLAMMATORY DISEASE | 565 | ||
| TREATMENT OF GONORRHEA AND CHLAMYDIA | 565 | ||
| FURTHER READING | 567 | ||
| CHAPTER 39. Syphilis | 568 | ||
| EPIDEMIOLOGY | 568 | ||
| CLINICAL PRESENTATION | 568 | ||
| DIAGNOSIS | 570 | ||
| TREATMENT | 573 | ||
| ASSESSING THERAPEUTIC RESPONSE | 573 | ||
| MANAGEMENT OF SEX PARTNERS | 575 | ||
| HIV AND SYPHILIS | 575 | ||
| FURTHER READING | 575 | ||
| CHAPTER 40. Genital Ulcer Disease | 577 | ||
| INTRODUCTION | 577 | ||
| HERPES SIMPLEX VIRUS (HSV) | 579 | ||
| CHANCROID | 582 | ||
| LYMPHOGRANULOMA VENEREUM (LGV) | 584 | ||
| GRANULOMA INGUINALE | 585 | ||
| FURTHER READING | 586 | ||
| SECTION 7: WORMS | 587 | ||
| CHAPTER 41. Common Intestinal Roundworms | 587 | ||
| GENERAL CONSIDERATIONS | 587 | ||
| ETIOLOGY | 588 | ||
| CLINICAL FEATURES | 588 | ||
| DIAGNOSIS | 588 | ||
| TREATMENT | 590 | ||
| ANISAKIASIS | 593 | ||
| FURTHER READING | 595 | ||
| CHAPTER 42. Cestodes: Intestinal and Extraintestinal Tapeworm Infections, Including Echinococcosis and Cysticercosis | 597 | ||
| DEMOGRAPHICS OF HUMAN TAPEWORMS INFECTION IN DEVELOPED NATIONS | 601 | ||
| FURTHER READING | 610 | ||
| CHAPTER 43. Filarial Infections | 611 | ||
| LYMPHATIC FILARIASIS | 611 | ||
| PREVENTION AND CONTROL | 618 | ||
| TROPICAL EOSINOPHILIA SYNDROME | 618 | ||
| ONCHOCERCIASIS | 620 | ||
| STREPTOCERCIASIS | 622 | ||
| LOIASIS | 623 | ||
| PERSTANS FILARIASIS | 624 | ||
| MANSONELLA OZZARDI INFECTION | 624 | ||
| FURTHER READING | 625 | ||
| CHAPTER 44. Trematodes | 626 | ||
| SCHISTOSOMIASIS | 626 | ||
| HEPATOBILIARY FLUKES: CLONORCHIS AND OPISTHORCHIS | 631 | ||
| HEPATOBILIARY FLUKES: FASCIOLA HEPATICA | 632 | ||
| LUNG FLUKES | 633 | ||
| INTESTINAL FLUKES | 634 | ||
| FURTHER READING | 635 | ||
| CHAPTER 45. The Eosinophilic Patient with Suspected Parasitic Infection | 637 | ||
| CLINICAL FEATURES | 637 | ||
| DIAGNOSIS | 639 | ||
| LABORATORY STUDIES IN EOSINOPHILIA | 639 | ||
| SPECIFIC INFECTIONS | 640 | ||
| FURTHER READING | 649 | ||
| Appendix | 650 | ||
| Index | 655 |